Companies

The pharmaceutical sector is highly profitable and resistant to recession, with global annual sales topping one trillion US dollars. Its main players such as Johnson & Johnson, Pfizer, GlaxoSmithKline, Novartis, Merck, Bayer and Sanofi-Aventis, are among the most innovative and dynamic organisations in the world. Reports in this section enable you to plot their next move, in terms of new drug and therapeutic pipelines, technologies and more. Also featured in the Pharmaceutical Companies section are many of the niche players: their cutting edge research and products offer excellent opportunities for business partnerships and investment. So whatever your interest – OTC pharmaceuticals, generics or leading brand names – or intention, there is a report or company profile to meet your need for the latest data and trends. Show Less ... more

• Diagnostica and Analys Service AB

  EURO€ 50.00USD$ 65.00GBP£ 42.00AUD$ 64.00JPY¥ 6,422.00SEK 427,00CHF 61.00CAD$ 66.00 Bioseeker, May 2013
  Our company report database is updated both through companies own participation and BioSeeker Group’s research. Daily updates and work with Sweden’s biotech companies make these company reports the...

• Top 10 Pharmaceutical Companies: Media Monitor

  EURO€ 1,842.00USD$ 2,397.00GBP£ 1,550.00AUD$ 2,344.00JPY¥ 236,645.00SEK 15 737,00CHF 2'259.00CAD$ 2,442.00 Moreover Technologies, May 2013
  Companies monitored: Pfizer GlaxoSmithKline Novartis Sanofi-Aventis AstraZeneca Hoffmann–La Roche Johnson & Johnson Merck & Co Abbott Eli Lilly and Company About the service: When pharma company news...

• BioSeek Plc - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Dec 2012 , Pages: 58
  BioSeek Plc – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “BioSeek Plc - Product Pipeline Review - 2012” provides data on the BioSeek Plc’s research and development...

• Shanghai CP Guojian Pharmaceutical Co.,Ltd. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Dec 2012 , Pages: 16
  Shanghai CP Guojian Pharmaceutical Co.,Ltd. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Shanghai CP Guojian Pharmaceutical Co.,Ltd. - Product Pipeline...

• Vyteris, Inc. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Dec 2012 , Pages: 29
  Vyteris, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Vyteris, Inc. - Product Pipeline Review - 2012” provides data on the Vyteris, Inc.’s research...

• MarcoPolo Pharmaceuticals SA - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Dec 2012 , Pages: 19
  MarcoPolo Pharmaceuticals SA – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “MarcoPolo Pharmaceuticals SA - Product Pipeline Review - 2012” provides data on...

• Grunenthal GmbH - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Dec 2012 , Pages: 76
  Grunenthal GmbH – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Grunenthal GmbH - Product Pipeline Review - 2012” provides data on the Grunenthal GmbH’s research...

• Graceway Pharmaceuticals, LLC - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Dec 2012 , Pages: 34
  Graceway Pharmaceuticals, LLC – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Graceway Pharmaceuticals, LLC - Product Pipeline Review - 2012” provides data...

• Creative Antibiotics Sweden AB - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Dec 2012 , Pages: 23
  Creative Antibiotics Sweden AB – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Creative Antibiotics Sweden AB - Product Pipeline Review - 2012” provides data...

• Sentinext Therapeutics Sdn Bhd - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Dec 2012 , Pages: 18
  Sentinext Therapeutics Sdn Bhd – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Sentinext Therapeutics Sdn Bhd - Product Pipeline Review - 2012” provides data...

• Handok Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Dec 2012 , Pages: 83
  Handok Pharmaceuticals Co., Ltd. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “HANDOK Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2012” provides...

• Laboratoris Sanifit S.L. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Dec 2012 , Pages: 19
  Laboratoris Sanifit S.L. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Laboratoris Sanifit S.L. - Product Pipeline Review - 2012” provides data on the Laboratoris...

• Rovi Pharmaceuticals Laboratories - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Dec 2012 , Pages: 27
  Rovi Pharmaceuticals Laboratories – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Rovi Pharmaceuticals Laboratories - Product Pipeline Review - 2012” provides...

• Melior Discovery, Inc. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Dec 2012 , Pages: 29
  Melior Discovery, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Melior Discovery, Inc. - Product Pipeline Review - 2012” provides data on the Melior...

• Ore Pharmaceuticals Inc - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Dec 2012 , Pages: 30
  Ore Pharmaceuticals Inc – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Ore Pharmaceuticals Inc - Product Pipeline Review - 2012” provides data on the Ore...

• Cosmix Molecular Biologicals GmbH - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 19
  Cosmix Molecular Biologicals GmbH – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Cosmix Molecular Biologicals GmbH - Product Pipeline Review - 2012” provides...

• DesignMedix, Inc. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 20
  DesignMedix, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “DesignMedix, Inc. - Product Pipeline Review - 2012” provides data on the DesignMedix, Inc.’s...

• Viral Genetics, Inc. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 29
  Viral Genetics, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Viral Genetics, Inc. - Product Pipeline Review - 2012” provides data on the Viral Genetics,...

• Baxter Healthcare Corporation - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 47
  Baxter Healthcare Corporation – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Baxter Healthcare Corporation - Product Pipeline Review - 2012” provides data...

• The Medicines Company - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 73
  The Medicines Company – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “The Medicines Company - Product Pipeline Review - 2012” provides data on the The Medicines...

• Vaxeal Holding SA - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 20
  Vaxeal Holding SA – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Vaxeal Holding SA - Product Pipeline Review - 2012” provides data on the Vaxeal Holding SA’s...

• Allozyne, Inc. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 29
  Allozyne, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Allozyne, Inc. - Product Pipeline Review - 2012” provides data on the Allozyne, Inc.’s research...

• NeurAxon, Inc. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 32
  NeurAxon, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “NeurAxon, Inc. - Product Pipeline Review - 2012” provides data on the NeurAxon, Inc.’s research...

• Vakzine Projekt Management GmbH - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 23
  Vakzine Projekt Management GmbH – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Vakzine Projekt Management GmbH - Product Pipeline Review - 2012” provides...

• Upsher-Smith Laboratories, Inc. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 45
  Upsher-Smith Laboratories, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Upsher-Smith Laboratories, Inc. - Product Pipeline Review - 2012” provides...

• Medicure Inc. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 39
  Medicure Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Medicure Inc. - Product Pipeline Review - 2012” provides data on the Medicure Inc.’s research...

• Bio-Bridge Science, Inc. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 30
  Bio-Bridge Science, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Bio-Bridge Science, Inc. - Product Pipeline Review - 2012” provides data on the Bio-Bridge...

• Tamir Biotechnology, Inc. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 47
  Tamir Biotechnology, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Tamir Biotechnology, Inc. - Product Pipeline Review - 2012” provides data on the...

• Neurotune AG - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 33
  Neurotune AG – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Neurotune AG - Product Pipeline Review - 2012” provides data on the Neurotune AG’s research and...

• Clavis Pharma ASA - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 99
  Clavis Pharma ASA – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Clavis Pharma ASA - Product Pipeline Review - 2012” provides data on the Clavis Pharma ASA’s...

• Dermadis SA - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 22
  Dermadis SA – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Dermadis SA - Product Pipeline Review - 2012” provides data on the Dermadis SA’s research and development...

• Pergamum AB - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 36
  Pergamum AB – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Pergamum AB - Product Pipeline Review - 2012” provides data on the Pergamum AB’s research and development...

• VBI Vaccines - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 30
  VBI Vaccines – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “VBI Vaccines - Product Pipeline Review - 2012” provides data on the VBI Vaccines’s research and...

• Alvine Pharmaceuticals, Inc. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 39
  Alvine Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Alvine Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on...

• BioNumerik Pharmaceuticals, Inc. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 27
  BioNumerik Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “BioNumerik Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides...

• ViroMed Co., Ltd. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 34
  ViroMed Co., Ltd. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “ViroMed Co., Ltd. - Product Pipeline Review - 2012” provides data on the ViroMed Co., Ltd.’s...

• Xenetic Biosciences plc - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 71
  Xenetic Biosciences plc – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Xenetic Biosciences plc - Product Pipeline Review - 2012” provides data on the Xenetic...

• NovaBay Pharmaceuticals, Inc. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 59
  NovaBay Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “NovaBay Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data...

• Cempra, Inc. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 49
  Cempra, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Cempra, Inc. - Product Pipeline Review - 2012” provides data on the Cempra, Inc.’s research and...

• Laurantis Pharma Oy - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 34
  Laurantis Pharma Oy – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Laurantis Pharma Oy - Product Pipeline Review - 2012” provides data on the Laurantis Pharma...

• Neurologix, Inc. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 31
  Neurologix, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Neurologix, Inc. - Product Pipeline Review - 2012” provides data on the Neurologix, Inc.’s...

• GlycoVaxyn AG - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 29
  GlycoVaxyn AG – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “GlycoVaxyn AG - Product Pipeline Review - 2012” provides data on the GlycoVaxyn AG’s research...

• Provid Pharmaceuticals, Inc. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 31
  Provid Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Provid Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on...

• GinkgoPharma Co. Ltd. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 18
  GinkgoPharma Co. Ltd. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “GinkgoPharma Co. Ltd. - Product Pipeline Review - 2012” provides data on the GinkgoPharma...

• Immune Technologies and Medicine - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 17
  Immune Technologies and Medicine – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Immune Technologies and Medicine - Product Pipeline Review - 2012” provides...

• Intas Pharmaceuticals Ltd. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 81
  Intas Pharmaceuticals Ltd. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Intas Pharmaceuticals Ltd. - Product Pipeline Review - 2012” provides data on the...

• NeoStem, Inc. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 86
  NeoStem, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “NeoStem, Inc. - Product Pipeline Review - 2012” provides data on the NeoStem, Inc.’s research...

• Tengion, Inc. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 60
  Tengion, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Tengion, Inc. - Product Pipeline Review - 2012” provides data on the Tengion, Inc.’s research...

• Discovery Genomics, Inc. - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 21
  Discovery Genomics, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Discovery Genomics, Inc. - Product Pipeline Review - 2012” provides data on the Discovery...

• Neurim Pharmaceuticals Ltd - Product Pipeline Review - 2012

  EURO€ 1,153.00USD$ 1,500.00GBP£ 970.00AUD$ 1,467.00JPY¥ 148,099.00SEK 9 849,00CHF 1'414.00CAD$ 1,528.00 Global Markets Direct, Nov 2012 , Pages: 48
  Neurim Pharmaceuticals Ltd – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Neurim Pharmaceuticals Ltd - Product Pipeline Review - 2012” provides data on the...